Terumo Introduces Azur® Detachable 35 Peripheral Framing Coil®
Truly Detachable .035” Framing Coil Precisely Scaffolds the Targeted Area in Peripheral Embolization Procedures
SOMERSET, NJ (March 26, 2012) – Terumo Interventional Systems, a strategic business unit of Terumo Medical Corporation, and a manufacturer of guidewires, catheters, sheaths,
and embolization products, announced the nationwide availability of the Azur® D35 Framing Coil, a truly detachable coil that precisely frames the targeted area for peripheral embolization.
The new Azur D35 Framing Coil is indicated for peripheral embolization procedures where a
scaffolding structure is needed, such as hypogastric artery embolization, peripheral arteriovenous malformations and fistulas, endoleaks, visceral aneurysms, and venous applications. The detachable embolic platform forms a spherical, 3-dimensional shape when deployed and is designed to control the first coil deployment when a standard coil would not suffice due to high flow and high pressures.
Chris Pearson, Vice President, Marketing, Terumo Interventional Systems, said, “These detachable framing coils afford greater filling capacity, packing density, and mechanical occlusion, particularly in the treatment of high-flow and challenging blood vessels, vascular malformations, and aneurysms.”
According to Pearson, the Azur D35 Framing Coil offers enhanced delivery control that allows
for precise placement prior to final deployment.
“The detachable technology allows the physician to optimize the framing coil placement,
creating support for subsequent coils,” said Pearson. “AZUR D35 Hydrogel coils expand gradually upon exposure to blood, which provides improved volumetric filling, allowing highly effective, targeted embolization.”
For more information about the Azur product line, customers can contact Terumo Interventional Systems at 800-862-4143 or by visiting http://www.terumois.com.
